Herpes retargeting, such as a) the use

Herpes simplex virus (HSV), a neurotropic DNA virus has many
advantageous properties as a gene delivery vector, just like all viruses HSV
also exhibits a natural tropism for specific cell types within the body. HSV
has the ability to infect almost every cell in the body, thus beneficial to retarget
virus infectivity in order to accomplish selective target cell infection. A method known as retargeting can be performed
to ensure the delivery of the viral vector to the intended cell or tissue. This
limits viral vector infection to only the desired target cell.  


An array of retargeting
studies over the years have significantly enhanced the understanding of HSV
entry. This ultimately led to the development of fully retargeted HSV vectors.  Retargeting can be performed to either expand or
restrict the tropism of viruses that affect a number of cell types. However, unlike
other enveloped viruses such as HIV and influenza which use one or more
glycoproteins to bind and enter host cells, HSV or members of the herpesvirus
family rely on a range of glycoproteins (HSV encodes 12 different glycoproteins)
to enter cells. This association of various glycoproteins in attachment and
entry process has proven to pose several challenges in retargeting of HSV as
many of these glycoproteins contribute to viral tropism. Therefore,
understanding the interaction and contribution of HSV gD, gC, gB, and gH/gL
(essential glycoproteins for entry) in attachment and entry is crucial in
retargeting HSV. HSV gB and gC encounter and bind to heparin sulfate
proteoglycan (HSPG) present in many cells of the body. This interaction initiates
binding to specific entry receptors for example, binding of gD with the TNF
receptor superfamily member HVEM or nectin-1, etc.  

Best services for writing your paper according to Trustpilot

Premium Partner
From $18.00 per page
4,8 / 5
Writers Experience
Recommended Service
From $13.90 per page
4,6 / 5
Writers Experience
From $20.00 per page
4,5 / 5
Writers Experience
* All Partners were chosen among 50+ writing services by our Customer Satisfaction Team


strategies have been employed for HSV vector retargeting, such as a) the use of
pseudotyped virus (e.g. G-glycoprotein from vesicular stomatitis virus (VSV-G)
pseudotyped various viruses), replacing one or more HSV glycoproteins with
those of another virus which has a different natural tropism. This has
illustrated that HSV-1 entry mechanism can be manipulated, b) the use of
adapter molecules that are capable of binding to both HSV gD and the desired
target receptor, though require the virus to be mixed with adapter prior to
infection in order to gain entry via target receptor, c) Finally, the incorporation
of peptide ligands and single-chain antibodies (scFvs) (findings from
Campadelli-Fiume group) into HSV gD, gC or gH with the combination of specific
deletions and mutations have enabled complete retargeting. Studies
relating to this have been performed in order to restrict oncolytic HSV (oHSV)
infection to only specific tumor cell types by replacing canonical
receptor-binding sequences, this retargeting strategy has been proven most


findings (Fan,2017)